The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000170325
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
21/01/2026
Date registered
Help: Date registered
10/02/2026
Date last updated
Help: Date last updated
10/02/2026
Date data sharing statement initially provided
Help: Data sharing statement date
10/02/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Changing Anxiety Response with Emotional Support (CARES)
Scientific title
Investigating the impact of psychosocial intervention for patients reporting anxiety in hospital following a traumatic injury on 6 month reported anxiety levels (compared to a retrospective cohort)
Additional trial identifiers [1] 316312 0
None
Universal Trial Number (UTN)
Trial acronym
CARES
Related trial records

Health condition
Health condition(s) studied:
Anxiety 340414 0
Condition category
Condition code
Mental Health 336625 336625 0 0
Anxiety

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Study participants will receive an intervention phone call from a Social Worker or Clinical Psychologist within 5-7 days of completing the screening tools [EuroQOL 5 Dmension 5 Level((EQ5D-5L), Primary Care PTSD screen for DSM-5 (PC-PTSD-5), Kessler 10 (K10) and Multidimensional Scale of Perceived Social Support )MSPSS)] in order to triage the participant for social work or psychology intervention and undertake initial goal setting. If scores indicate high distress, the research assistant or project lead will alert the Social worker (SW) and/or psychologist for priority call for risk assessment and treatment as indicated.
The appropriate clinician and interventions to be delivered will be identified based on the results from the questionnaires. Social Work interventions include assessment and interventions related to housing/financial/legal issues, social supports, or emotional support. Clinical Psychology interventions include psychosocial support with focus on psychoeducation, psychological first aid, trauma informed emotional support and coping strategies. Both interventions will provide the patient with personalised resources, dependent on patient needs eg information regarding child support, family violence, Lifeline etc. The sessions will take place via phone call unless the patient has a strong desire for face to face meetings which could be facilitated. Depending upon the levels of distress and/or concerns raised by the participants in both response to the questionnaires and/ in the phone contact, psychology and/social work interventions will be provided as deemed clinically necessary. Community referrals will be facilitated as required, and duration and frequency of sessions will be considered in line with psychology and social work professional duty of care standards, hence the total duration is unknown but we anticipate that the follow up will be less than 2 months. Session completion records including length and number of treatments will be recorded.
Intervention code [1] 333012 0
Treatment: Other
Intervention code [2] 333068 0
Behaviour
Description of the comparator or control
Retrospective control group - Patients admitted to the Alfred Hospital trauma ward (5 West) who reported greater than moderate on the EQ5D-5L in the two years prior to study commencement (January 01 2023 to Dec 31 2024). These patients did not receive follow up phone care or intervention.
Control group
Historical

Outcomes
Primary outcome [1] 344133 0
The primary outcome is distress levels on EuroQol-5Dimension 5 Levels of severity (EQ5D-5L) at 6 months comparing participants in the intervention group with a similar cohort in the baseline group. We will account for any confounding factors e.g., pre-morbid anxiety levels using regression analysis.
Timepoint [1] 344133 0
6 months following injury
Secondary outcome [1] 456839 0
Secondary outcome is Return to work (for those working prior to injury) at 6 months comparing participants in the intervention group with a similar cohort in the baseline group. We will account for any confounding factors e.g., pre-morbid anxiety levels using regression analysis.
Timepoint [1] 456839 0
6 months following injury which lead to hospitalisation
Secondary outcome [2] 457139 0
Secondary outcome is quality of life (for those working prior to injury) at 6 months comparing participants in the intervention group with a similar cohort in the baseline group. We will account for any confounding factors e.g., pre-morbid anxiety levels using regression analysis.
Timepoint [2] 457139 0
6 months following injury which lead to hospitalisation
Secondary outcome [3] 457140 0
Secondary outcome is residential status (for those working prior to injury) at 6 months comparing participants in the intervention group with a similar cohort in the baseline group. We will account for any confounding factors e.g., pre-morbid anxiety levels using regression analysis.
Timepoint [3] 457140 0
6 months following hospitalisation
Secondary outcome [4] 457141 0
secondary outcome is patent function and pain at 6 months comparing participants in the intervention group with a similar cohort in the baseline group. This is collected by registry data - registry based outcome (VOTOR or VSTR). We will account for any confounding factors e.g., pre-morbid anxiety levels using regression analysis.
Timepoint [4] 457141 0
6 months following injury resulting in hospitalisation

Eligibility
Key inclusion criteria
All patients admitted to the trauma unit at The Alfred between 1/2/2026 to 31/1/2027 who meet study eligibility criteria will be approached regarding study inclusion:
Inclusion criteria
- Age 18 years or older
- Admitted to The Alfred trauma ward following a traumatic incident
- Able to provide written informed consent
- EQ-5D is a routinely administered questionnaire as part of usual care: threshold for study inclusion is an anxiety/depression score =moderate on hospital admission or discharge (approximately 250 patients/year)
- Valid Medicare card
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
discharge destination is prison
unable to consent for themselves

Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Other
Other design features
Use of historical cohort as previously described
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC

Funding & Sponsors
Funding source category [1] 320907 0
Government body
Name [1] 320907 0
Transport Accident Commission
Country [1] 320907 0
Australia
Funding source category [2] 320953 0
Government body
Name [2] 320953 0
Transport Accident Commission
Country [2] 320953 0
Australia
Primary sponsor type
Hospital
Name
Alfred Health
Address
Country
Australia
Secondary sponsor category [1] 323649 0
None
Name [1] 323649 0
Address [1] 323649 0
Country [1] 323649 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 319449 0
Alfred Hospital Ethics Committee
Ethics committee address [1] 319449 0
Ethics committee country [1] 319449 0
Australia
Date submitted for ethics approval [1] 319449 0
24/11/2025
Approval date [1] 319449 0
07/01/2026
Ethics approval number [1] 319449 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 147358 0
A/Prof Lara Kimmel
Address 147358 0
Bayside Health: Alfred Care Group. 55 Commercial Rd, Melbourne, Victoria. 3004
Country 147358 0
Australia
Phone 147358 0
+61 419501387
Fax 147358 0
Email 147358 0
Contact person for public queries
Name 147359 0
Lara Kimmel
Address 147359 0
Bayside Health: Alfred Care Group. 55 Commercial Rd, Melbourne VIC 3004
Country 147359 0
Australia
Phone 147359 0
+61 419501387
Fax 147359 0
Email 147359 0
Contact person for scientific queries
Name 147360 0
Lara Kimmel
Address 147360 0
Bayside Health: Alfred Care Group. 55 Commercial Rd, Melbourne, Victoria. 3004
Country 147360 0
Australia
Phone 147360 0
+61 419501387
Fax 147360 0
Email 147360 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

TypeCitationLinkEmailOther DetailsAttachment
Ethical approval    122457 (Local Reference 697-25) Ethics Approval 07-Jan-2026.pdf


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.